Month: June 2020

News Clinical Trials Recombinant Novel Coronavirus Vaccine (adenovirus type 5 Vector) Received Military Specially-Needed Drug Approval in China Print this page Hong Kong, June 29, 2020 — This announcement is made by CanSino Biologics Inc. (the “Company”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong
0 Comments
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer Print this page South San Francisco, CA — June 29, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination (FDC) of Perjeta® (pertuzumab)
0 Comments
Top federal health officials told lawmakers Tuesday the U.S. needs a more unified national response and funding for public health funding if the country faces another pandemic.  The U.S. is now reporting nearly 40,000 new coronavirus cases every day — almost double from about 22,800 in mid-May — driven largely by outbreaks in a number of states
0 Comments
Atopic eczema wasn’t tied to a significantly increased risk for most cancers, according to research from England and Denmark. In an English matched-cohort of nearly 500,000 individuals with atopic eczema, there was little evidence to suggest an association between eczema and overall cancer incidence (adjusted hazard ratio [aHR] 1.04, 99% CI 1.02-1.06), reported Kathryn Mansfield,
0 Comments
Our group of college friends planned to attend alumni weekend in June. But cancer and COVID changed our plans. Through a series of messages, and phone calls, we heard the news: it is cancer. The cancer diagnosis and treatment planning all happened during COVID. We still wanted to celebrate our friendship, so we planned our
0 Comments
A country’s response to a monumental crisis is reliant upon political leadership that presents a united front. This was not the case when COVID-19 first struck the United States. Democrats and Republicans failed to see eye to eye on appropriate mitigation strategies at that point in time.  The public takes cues from elected Congressmen about behavioral changes they
0 Comments
With pinging mobiles and thumping music taking over every element of our day, silence is a rarity in the modern world. But, could switching off from these sounds help us improve our physical and emotional health? Can you hear that? It’s the sound of constant noise. We’re bombarded 24/7 by sounds of some sort –
0 Comments
Axillary vein puncture guided by ultrasound, using a readily learned technique, was superior to cephalic vein dissection via cut-down for implantation of cardiac device leads in a small, multicenter, randomized clinical trial from Brazil. Use of the axillary vein provided better success with shorter procedure time. In a comparison of the two approaches for pacemaker
0 Comments
With government support, three coronavirus vaccines are expected to be studied in large-scale clinical trials in the next three months. “The best we’ve ever done is measles, which is 97 to 98 percent effective,” said Fauci, the director of the National Institute of Allergy and Infectious Diseases. “That would be wonderful if we get there.
0 Comments
casimersen Treatment for Duchenne Muscular Dystrophy Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45 Print this page CAMBRIDGE, Mass., June 26, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today
0 Comments
Print this page CAMBRIDGE, Mass. and TARRYTOWN, N.Y., June 19, 2020 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a 300 mg single-dose pre-filled pen for Dupixent® (dupilumab). The pre-filled pen is approved for all Dupixent indications in patients aged 12 years and older, which includes use in certain patients with atopic dermatitis, asthma and chronic rhinosinusitis with
0 Comments
Anne Schuchat, director of the Centers for Disease Control (CDC), speaks during a U.S. Senate Committee on Health, Education, Labor, and Pensions hearing at the U.S. Capitol in Washington, D.C., on Tuesday, March 3, 2020. Stefani Reynolds | Bloomberg via Getty Images The coronavirus is spreading too rapidly and too broadly for the U.S. to
0 Comments
Glucose-lowering treatment regimens should be tailored to patients’ specific risk factors, but should largely include a foundation of metformin, researchers reported. In a systematic review and network meta-analysis (NMA) of over 450 trials spanning 21 antidiabetic therapies, the greatest reduction in HbA1c levels was seen when insulin and certain GLP-1 receptor agonists were added to
0 Comments
The US Food and Drug Administration (FDA) has approved oral octreotide (Mycapssa, Chiasma) delayed-release capsules for the long-term maintenance treatment of patients with acromegaly who previously responded to and tolerated octreotide or lanreotide injections. “People living with acromegaly experience many challenges associated with injectable therapies and are in need of new treatment options,” said Jill
0 Comments